Skip to content
Dose Brief
Menu
No. 60 on the board · Grade C

Cora Health review

Cora Health is a direct-to-consumer telehealth platform offering compounded semaglutide ($99–$175/mo) and tirzepatide ($135–$225/mo) with flat per-tier pricing — no surcharge as your dose escalates.

Visit Cora Health Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the score.
Semaglutide
From $99/mo (all doses, 12-month plan, compounded)
Tirzepatide
From $135/mo (all doses, 12-month plan, compounded)
Coverage
All 50 states
Brand-name
Compounded only
On the trackerNewnew to the tracker, no prior readingNew to the tracker on 1 August 2026. The published line reads From $99/mo (all doses, 12-month plan, compounded) at our first reading; there is no earlier reading of ours to compare it against yet.

The scorecard

Cora Health scored on our six Brief Score factors. See the methodology.

Price Stability66/100
Supply Reliability73/100
Transparency88/100
Access Breadth90/100
Clinical Oversight83/100
Track Record68/100

What we like

  • Two named 503A compounding pharmacy partners disclosed on first-party pages (Hallandale Pharmacy + VialsRx)
  • Hallandale Pharmacy is PCAB-accredited and operating since 2003 (independently verified)
  • LegitScript Certified (seal ID 49690100 in footer)
  • Flat per-tier pricing — no dose-escalation surcharge
  • Annual commitment delivers $99/mo semaglutide and $135/mo tirzepatide

The caveats

  • Compounded medications are not FDA-approved and not therapeutically equivalent to Wegovy/Zepbound
  • Leanio Health LLC has zero independent operating-history footprint (no BBB, no press, likely <12 months old)
  • Lowest advertised prices require 12-month commitment with no partial refunds
  • No brand-name Wegovy/Zepbound or oral GLP-1 (orforglipron/Rybelsus) options
  • Founder names and funding undisclosed on site

The brief

Best for: Readers who want flat-rate compounded GLP-1 from $99/mo with named pharmacy disclosure. Cora Health is a direct-to-consumer telehealth platform offering compounded semaglutide ($99–$175/mo) and tirzepatide ($135–$225/mo) with flat per-tier pricing — no surcharge as your dose escalates.

Ranked #60 of 495 providers we reviewed — see our #1 pick, CoreAge Rx, for comparison.

Closest on the board

The desks scoring nearest Cora Health — the realistic shortlist if you're weighing it.

Weighing Cora Health against one desk in particular? We file it head to head with our top-ranked pick in CoreAge Rx vs Cora Health, and every desk that outranks it is listed on the Cora Health alternatives board.

More desks we track (24)

464 more are filed too — see every desk we track, ranked.

Pricing, states and verification reflect Cora Health's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on Cora Health's site. Not medical advice; see our disclosure.

← Back to all rankings